| Literature DB >> 29128649 |
Carmen P McLean1, Sheila A M Rauch2, Edna B Foa3, Rebecca K Sripada4, Hallie S Tannahill5, Jim Mintz6, Jeffrey Yarvis7, Stacey Young-McCaughan8, Katherine A Dondanville9, Brittany N Hall-Clark10, Brooke A Fina11, Terence M Keane12, Alan L Peterson13.
Abstract
Improved accessibility of effective and efficient evidence-based treatments (EBTs) for military personnel suffering with posttraumatic stress disorder (PTSD) is an urgent need to meet the growing demand for timely care. In addition, a better understanding of the mechanism of action of behavioral therapy can inform the delivery of care to meet accessibility demands. Effective EBTs for PTSD are available, but logistical and stigma-related barriers to accessing behavioral healthcare can deter military personnel from receiving these treatments. Web-based treatments represent an innovative way to overcome these barriers. The efficacy of previously developed web-based treatments for PTSD appears promising; however, they were not developed based on treatment protocols with strong empirical support for their efficacy. No study to date has examined web-based treatment of PTSD using a well-established evidence-based treatment, nor delineated the biological mechanisms through which a web-based treatment exerts its effects. This paper describes the rationale and methods of a randomized controlled trial comparing the efficacy and potential biological mediators of 10 sessions of a web-version of Prolonged Exposure (PE), "Web-PE," delivered over 8weeks compared to 10 sessions of in-person Present-Centered Therapy (PCT) delivered over 8weeks by a therapist in 120 active duty military personnel and veterans with PTSD.Entities:
Keywords: Biomarkers; Military behavioral health; Posttraumatic stress disorder; Prolonged exposure; Treatment mechanisms; Web-treatment
Mesh:
Year: 2017 PMID: 29128649 DOI: 10.1016/j.cct.2017.11.008
Source DB: PubMed Journal: Contemp Clin Trials ISSN: 1551-7144 Impact factor: 2.226